155 related articles for article (PubMed ID: 18000605)
1. Factor VIIa and tissue factor procoagulant activity in diabetes mellitus after acute ischemic stroke: impact of hyperglycemia.
Gentile NT; Vaidyula VR; Kanamalla U; DeAngelis M; Gaughan J; Rao AK
Thromb Haemost; 2007 Nov; 98(5):1007-13. PubMed ID: 18000605
[TBL] [Abstract][Full Text] [Related]
2. Whole-blood tissue factor procoagulant activity is elevated in type 1 diabetes: effects of hyperglycemia and hyperinsulinemia.
Singh A; Boden G; Homko C; Gunawardana J; Rao AK
Diabetes Care; 2012 Jun; 35(6):1322-7. PubMed ID: 22410811
[TBL] [Abstract][Full Text] [Related]
3. Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: effects of insulin and glucose.
Boden G; Vaidyula VR; Homko C; Cheung P; Rao AK
J Clin Endocrinol Metab; 2007 Nov; 92(11):4352-8. PubMed ID: 17785358
[TBL] [Abstract][Full Text] [Related]
4. Study of factor VII, tissue factor pathway inhibitor and monocyte tissue factor in noninsulin-dependent diabetes mellitus.
El-Ghoroury EA; El-Din HG; Abdel-Kader M; Ragab S
Blood Coagul Fibrinolysis; 2008 Jan; 19(1):7-13. PubMed ID: 18180609
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of somatostatin on circulating tissue factor procoagulant activity and protein.
Boden G; Vaidyula V; Homko C; Mozzoli M; Rao AK
Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1333-9. PubMed ID: 17213471
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor and Toll-like receptor (TLR)4 in hyperglycaemia-hyperinsulinaemia. Effects in healthy subjects, and type 1 and type 2 diabetes mellitus.
Singh A; Boden G; Rao AK
Thromb Haemost; 2015 Apr; 113(4):750-8. PubMed ID: 25653143
[TBL] [Abstract][Full Text] [Related]
7. Can MiR-503 be used as a marker in diabetic patients with ischemic stroke?
Sheikhbahaei S; Manizheh D; Mohammad S; Hasan TM; Saman N; Laleh R; Mahsa M; Sanaz AK; Shaghayegh HJ
BMC Endocr Disord; 2019 Apr; 19(1):42. PubMed ID: 31035988
[TBL] [Abstract][Full Text] [Related]
8. Coagulation markers and functional outcome in acute ischemic stroke: Impact of intensive versus standard hyperglycemia control.
Gentile NT; Rao AK; Reimer H; Del Carpio-Cano F; Ramakrishnan V; Pauls Q; Barsan WG; Bruno A;
Res Pract Thromb Haemost; 2021 Jul; 5(5):e12563. PubMed ID: 34278192
[TBL] [Abstract][Full Text] [Related]
9. Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease.
Vaidyula VR; Criner GJ; Grabianowski C; Rao AK
Thromb Res; 2009 Jul; 124(3):259-61. PubMed ID: 19162305
[TBL] [Abstract][Full Text] [Related]
10. Assessing Circulating Factor VIIa-Antithrombin Complexes in Acute Ischemic Stroke: A Pilot Study.
Słomka A; Świtońska M; Sinkiewicz W; Żekanowska E
Clin Appl Thromb Hemost; 2017 May; 23(4):351-359. PubMed ID: 26873107
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of factor XIIa and factor VIIa are increased but not related in primary hyperlipidaemia.
Cardigan RA; Crook M; Mackie IJ; Machin SJ
Blood Coagul Fibrinolysis; 2001 Apr; 12(3):187-92. PubMed ID: 11414632
[TBL] [Abstract][Full Text] [Related]
12. Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease.
Rao AK; Vaidyula VR; Bagga S; Jalagadugula G; Gaughan J; Wilhite DB; Comerota AJ
Thromb Haemost; 2006 Dec; 96(6):738-43. PubMed ID: 17139367
[TBL] [Abstract][Full Text] [Related]
13. Activated factor XI is associated with increased factor VIIa - Antithrombin complexes in stable coronary artery disease: Impact on cardiovascular outcomes.
Paszek E; Pociask E; Ząbczyk M; Butenas S; Undas A
Eur J Clin Invest; 2022 Dec; 52(12):e13857. PubMed ID: 35996895
[TBL] [Abstract][Full Text] [Related]
14. Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria.
Kario K; Matsuo T; Kobayashi H; Matsuo M; Sakata T; Miyata T
Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1114-20. PubMed ID: 7627704
[TBL] [Abstract][Full Text] [Related]
15. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease.
Key NS; Slungaard A; Dandelet L; Nelson SC; Moertel C; Styles LA; Kuypers FA; Bach RR
Blood; 1998 Jun; 91(11):4216-23. PubMed ID: 9596669
[TBL] [Abstract][Full Text] [Related]
16. Seminal factor VII and factor VIIa: supporting evidence for the presence of an active tissue factor-dependent coagulation pathway in human semen.
Lwaleed BA; Goyal A; Delves G; Gossai S; Greenfield RS; Cooper AJ
Int J Androl; 2007 Dec; 30(6):543-9. PubMed ID: 17459125
[TBL] [Abstract][Full Text] [Related]
17. Postprandial elevation of activated factor VII in young adults.
Kapur R; Hoffman CJ; Bhushan V; Haltin MB
Arterioscler Thromb Vasc Biol; 1996 Nov; 16(11):1327-32. PubMed ID: 8911270
[TBL] [Abstract][Full Text] [Related]
18. Associations of activated coagulation factor VII and factor VIIa-antithrombin levels with genome-wide polymorphisms and cardiovascular disease risk.
Olson NC; Raffield LM; Lange LA; Lange EM; Longstreth WT; Chauhan G; Debette S; Seshadri S; Reiner AP; Tracy RP
J Thromb Haemost; 2018 Jan; 16(1):19-30. PubMed ID: 29112333
[TBL] [Abstract][Full Text] [Related]
19. Factor VIIa-antithrombin complex: a possible new biomarker for activated coagulation.
Spiezia L; Campello E; Valle FD; Woodhams B; Simioni P
Clin Chem Lab Med; 2017 Mar; 55(4):484-488. PubMed ID: 27522621
[TBL] [Abstract][Full Text] [Related]
20. Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men.
Rao AK; Chouhan V; Chen X; Sun L; Boden G
Diabetes; 1999 May; 48(5):1156-61. PubMed ID: 10331423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
